Coronary heart disease (CHD) and stroke are major cases of death in U.S. and all other industrialized nations. High dietary cholesterol is now well recognized as a major atherosclerotic risk factor. In addition to the quantity of cholesterol and total fat consumed, the type and source of fat also are known to be important in determining atherosclerosis risk. For example, saturated fatty acid consumption raises plasma cholesterol and atherosclerosis risk, while consumption of vegetable oils high in polyunsaturated fatty acids appear to lower them. Marine oils which are high in omega-3 fatty acids appear to be protective against CHD. To further clarify the role that various specific fatty acids play in atherosclerosis, we plan to measure by gas- liquid chromatography the relative concentrations of all saturated and unsaturated fatty acids found in the cholesterol ester and phospholipid fractions of plasma from 4,000 middle-aged subjects from the Minneapolis area who are participating in the Atherosclerosis Risk in Communities (ARIC) Study. The ARIC study is a large, milticenter, cooperative NIH funded study designed to investigate the etiology and natural history of atherosclerosis. Large amounts of clinical and laboratory data is collected along with direct visualization of the atherosclerotic process via ultrasound of the carotid and popliteal arteries. We plan to use these fatty acid data to investigate associations of plasma abundance of specific saturated, mononunsaturated, and polyunsaturated fatty acids with: 1) various physiologic parameters that are currently being measured by the ARIC study such as plasma lipids, hemostatic parameters, and blood pressure, and to look at these associations in subgroups according to age, sex, smoking status, etc., 2) ultrasonographically identified carotid artery atherosclerosis present on ARIC baseline or three year follow-up examination, 3) clinical cardiovascular endpoints of the the ARIC study, namely myocardial infarction and stroke, as these events occur in ARIC participants.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL040848-03
Application #
3358107
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Project Start
1988-07-01
Project End
1992-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Yamagishi, Kazumasa; Folsom, Aaron R; Steffen, Lyn M et al. (2013) Plasma fatty acid composition and incident ischemic stroke in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Cerebrovasc Dis 36:38-46
Wang, Lu; Folsom, Aaron R; Zheng, Zhi-Jie et al. (2003) Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 78:91-8
Wang, L; Folsom, A R; Eckfeldt, J H (2003) Plasma fatty acid composition and incidence of coronary heart disease in middle aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Nutr Metab Cardiovasc Dis 13:256-66
Ma, J; Folsom, A R; Lewis, L et al. (1997) Relation of plasma phospholipid and cholesterol ester fatty acid composition to carotid artery intima-media thickness: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 65:551-9
Ma, J; Folsom, A R; Shahar, E et al. (1995) Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Clin Nutr 62:564-71
Ma, J; Folsom, A R; Eckfeldt, J H et al. (1995) Short- and long-term repeatability of fatty acid composition of human plasma phospholipids and cholesterol esters. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Clin Nutr 62:572-8
Folsom, A R; Ma, J; Eckfeldt, J H et al. (1994) Plasma phospholipid fatty acid composition and factor VII coagulant activity. Atherosclerosis 111:199-207